The neuroimaging findings in CO-VID-19 patients A literature review | ||||
| Sohag Medical Journal | ||||
| Article 8, Volume 25, Issue 3, July 2021, Page 54-59 PDF (1019.17 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/smj.2021.79201.1257 | ||||
 View on SCiNiTO | ||||
| Author | ||||
yasser abdelkarim Amin  
| ||||
| diagnostic radiology department Sohag faculty of medicine sohag university | ||||
| Abstract | ||||
| In Wuhan, China, (SARS-CoV-2) began in December 2019 and rapidly distributed. The disease's clinical hallmark is viral pneumonia with Fever and non-productive cough. Patients may progress suddenly to acute respiratory distress syndrome and, in extreme cases, to death due to Multi-organ or respiratory failure. The neurological manifestations of the COVID-disease impact the outcome and the prognosis of the affected patients. The early diagnosis and treatment help in decreasing the acute manifestations and long-term effects. Imaging plays a crucial role in the detection and characterization of the CNS involvement's underlying etiology, giving the clinician the right route for the management. Functioning imaging like positron emission tomography (PET) and diffusion tensor imaging (DTI) are used to understanding the changes that occur in the affected area of the neural tissues. Aim: to clarify and revise the imaging findings in neurological presentations at COVID-19 patients. Conclusion: Corona-virus-2 affects the neural tissue either directly or indirectly leads to a mild or severe degree of clinical presentations. The clinicians and the neuroradiologist should be aware of early diagnosis and management to avoid a poor prognosis. | ||||
| Keywords | ||||
| COVID-19; Neuroimaging; CNS | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 211 PDF Download: 195 |
||||
